GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Piotroski F-Score

InnovAge Holding (InnovAge Holding) Piotroski F-Score : 4 (As of May. 09, 2024)


View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

InnovAge Holding has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for InnovAge Holding's Piotroski F-Score or its related term are showing as below:

INNV' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 5
Current: 4

During the past 5 years, the highest Piotroski F-Score of InnovAge Holding was 5. The lowest was 1. And the median was 2.


InnovAge Holding Piotroski F-Score Historical Data

The historical data trend for InnovAge Holding's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnovAge Holding Piotroski F-Score Chart

InnovAge Holding Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Piotroski F-Score
N/A N/A N/A 5.00 2.00

InnovAge Holding Quarterly Data
Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 2.00 2.00 2.00 4.00

Competitive Comparison of InnovAge Holding's Piotroski F-Score

For the Medical Care Facilities subindustry, InnovAge Holding's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InnovAge Holding's Piotroski F-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -6.63 + -11.177 + -10.304 + -3.447 = $-31.6 Mil.
Cash Flow from Operations was 29.075 + 13.151 + -32.985 + -9.294 = $-0.1 Mil.
Revenue was 172.539 + 176.874 + 182.485 + 188.898 = $720.8 Mil.
Gross Profit was 28.785 + 28.506 + 27.877 + 33.613 = $118.8 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(546.115 + 569.407 + 567.358 + 545.594 + 534.262) / 5 = $552.5472 Mil.
Total Assets at the begining of this year (Dec22) was $546.1 Mil.
Long-Term Debt & Capital Lease Obligation was $100.4 Mil.
Total Current Assets was $157.0 Mil.
Total Current Liabilities was $123.1 Mil.
Net Income was -2.821 + -12.709 + -13.073 + -9.793 = $-38.4 Mil.

Revenue was 177.359 + 172.86 + 171.218 + 167.456 = $688.9 Mil.
Gross Profit was 28.003 + 23.631 + 21.424 + 22.573 = $95.6 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(558.001 + 558.191 + 555.596 + 584.98 + 546.115) / 5 = $560.5766 Mil.
Total Assets at the begining of last year (Dec21) was $558.0 Mil.
Long-Term Debt & Capital Lease Obligation was $95.6 Mil.
Total Current Assets was $199.5 Mil.
Total Current Liabilities was $106.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

InnovAge Holding's current Net Income (TTM) was -31.6. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

InnovAge Holding's current Cash Flow from Operations (TTM) was -0.1. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-31.558/546.115
=-0.05778636

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-38.396/558.001
=-0.06880991

InnovAge Holding's return on assets of this year was -0.05778636. InnovAge Holding's return on assets of last year was -0.06880991. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

InnovAge Holding's current Net Income (TTM) was -31.6. InnovAge Holding's current Cash Flow from Operations (TTM) was -0.1. ==> -0.1 > -31.6 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=100.416/552.5472
=0.18173289

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=95.594/560.5766
=0.17052799

InnovAge Holding's gearing of this year was 0.18173289. InnovAge Holding's gearing of last year was 0.17052799. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=156.964/123.132
=1.27476204

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=199.489/106.185
=1.87869285

InnovAge Holding's current ratio of this year was 1.27476204. InnovAge Holding's current ratio of last year was 1.87869285. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

InnovAge Holding's number of shares in issue this year was 135.888. InnovAge Holding's number of shares in issue last year was 135.579. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=118.781/720.796
=0.16479143

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=95.631/688.893
=0.13881837

InnovAge Holding's gross margin of this year was 0.16479143. InnovAge Holding's gross margin of last year was 0.13881837. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=720.796/546.115
=1.3198612

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=688.893/558.001
=1.23457306

InnovAge Holding's asset turnover of this year was 1.3198612. InnovAge Holding's asset turnover of last year was 1.23457306. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+0+1+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

InnovAge Holding has an F-score of 4 indicating the company's financial situation is typical for a stable company.

InnovAge Holding  (NAS:INNV) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


InnovAge Holding Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


InnovAge Holding (InnovAge Holding) Business Description

Traded in Other Exchanges
N/A
Address
8950 East Lowry Boulevard, Denver, CO, USA, 80230
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
Executives
Teresa Sparks director 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Nicole Damato officer: CHIEF LEGAL OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Benjamin C Adams officer: CHIEF FINANCIAL OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau director 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent officer: CHIEF OPERATIONS OFFICER 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully director 320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer officer: CHIEF MEDICAL OFFICER C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson director 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair officer: PRESIDENT 8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert director 580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh director 601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt director, officer: CEO, President and Director 8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano officer: CORPORATE COO 8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr officer: CHIEF SALES AND MKTG. OFFICER 8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch officer: CHIEF MEDICAL OFFICER 8950 E. LOWRY BLVD., DENVER CO 80230